drugset

drugset / Trial / NCT00637026

Ph II Early BC Pre-Surgical Biologic Study

NCT00637026 ↗

Phase 2 Completed 65 enrolled AstraZeneca Cancer International Research Group (CIRG) · collab

NaSingle-groupOpen-labelTreatment

Summary

A pre-surgery study to assess changes that occur in human breast cancer material and normal skin after a short course of treatment with Iressa.

Timeline

Start: 2003-07
Primary completion: —
Completion: 2005-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gefitinib	Small molecule	—	—

Indications